A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
As the industry faces the depreciation of third-party cookies, pharma marketers and ad agencies are looking for new ways to effectively target diagnosed patients. Here are four tactics that can be launched in-market within a matter of weeks that allow brands to engage patients where they are – patient communities.
Google will end app tracking on Android, negatively impacting marketing – health marketers can avoid this with real world data, a privacy-safe solution.
Apple is compelling health marketers to adopt privacy-safe, AI-generated digital audiences created from offline RWD instead of online clickstream data.
Privacy issues are unavoidable, but are you prepared? Health marketers must develop deep awareness of their company, patient & advertising supply chain.
Swoop is an NAI member & must now disclose the demographic makeup & intended condition of its custom built audience of patients & healthcare providers.